- Protocol Short Name and Number: cGVHD Treatment, 0801
- Protocol Long Name: A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease
- Protocol (PDF)
- Informed Consent and Assent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0801 Protocol co-Chair: Paul Carpenter, MD, BS
- BMT CTN # 0801 Protocol co-Chair: Mukta Arora, MD
- BMT CTN # 0801 Protocol Officer: Marcelo Pasquini, MD
- BMT CTN # 0801 Protocol Coordinator: bmtctn@emmes.com
- BMT CTN # 0801 Medical Monitor: Bipin Savani
- Keywords: Treatment, Graft versus Host Disease, Graft vs. Host Disease, GVHD, Sirolimus, Quality of Life, QOL, Pediatric, Child, Children, Teen, Adolescent
The BMT CTN 0801 study closed to new patient accrual on December 9, 2013.